MNOV
Price
$1.31
Change
-$0.01 (-0.76%)
Updated
Apr 26, 6:59 PM EST
12 days until earnings call
VTVT
Price
$26.81
Change
+$0.42 (+1.59%)
Updated
Apr 26, 6:59 PM EST
Ad is loading...

MNOV vs VTVT ᐉ Comparison: Which is Better to Invest?

Header iconMNOV vs VTVT Comparison
Open Charts MNOV vs VTVTBanner chart's image
Medicinova
Price$1.31
Change-$0.01 (-0.76%)
Volume$4.56K
CapitalizationN/A
vTv Therapeutics
Price$26.81
Change+$0.42 (+1.59%)
Volume$400
CapitalizationN/A
View a ticker or compare two or three
MNOV vs VTVT Comparison Chart

Loading...

MNOVDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VTVTDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
MNOV vs. VTVT commentary
Apr 28, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MNOV is a Hold and VTVT is a Hold.

COMPARISON
Comparison
Apr 28, 2024
Stock price -- (MNOV: $1.31 vs. VTVT: $26.97)
Brand notoriety: MNOV and VTVT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MNOV: 15% vs. VTVT: 4%
Market capitalization -- MNOV: $64.25M vs. VTVT: $65.6M
MNOV [@Biotechnology] is valued at $64.25M. VTVT’s [@Biotechnology] market capitalization is $65.6M. The market cap for tickers in the [@Biotechnology] industry ranges from $568.92B to $0. The average market capitalization across the [@Biotechnology] industry is $2.58B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MNOV’s FA Score shows that 0 FA rating(s) are green whileVTVT’s FA Score has 0 green FA rating(s).

  • MNOV’s FA Score: 0 green, 5 red.
  • VTVT’s FA Score: 0 green, 5 red.
According to our system of comparison, both MNOV and VTVT are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MNOV’s TA Score shows that 4 TA indicator(s) are bullish while VTVT’s TA Score has 4 bullish TA indicator(s).

  • MNOV’s TA Score: 4 bullish, 5 bearish.
  • VTVT’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, VTVT is a better buy in the short-term than MNOV.

Price Growth

MNOV (@Biotechnology) experienced а -5.76% price change this week, while VTVT (@Biotechnology) price change was +12.17% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.69%. For the same industry, the average monthly price growth was -8.16%, and the average quarterly price growth was +1262.42%.

Reported Earning Dates

MNOV is expected to report earnings on May 10, 2024.

VTVT is expected to report earnings on Feb 28, 2024.

Industries' Descriptions

@Biotechnology (+1.69% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for MNOV with price predictions.
OPEN
A.I.dvisor published
a Summary for VTVT with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
VTVT($65.6M) and MNOV($64.3M) have the same market capitalization . VTVT YTD gains are higher at: 134.478 vs. MNOV (-12.667).
MNOVVTVTMNOV / VTVT
Capitalization64.3M65.6M98%
EBITDAN/AN/A-
Gain YTD-12.667134.478-9%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
MNOV vs VTVT: Fundamental Ratings
MNOV
VTVT
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
39
Fair valued
92
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
94100
PRICE GROWTH RATING
1..100
8335
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MNOV's Valuation (39) in the Biotechnology industry is somewhat better than the same rating for VTVT (92). This means that MNOV’s stock grew somewhat faster than VTVT’s over the last 12 months.

MNOV's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as VTVT (100). This means that MNOV’s stock grew similarly to VTVT’s over the last 12 months.

MNOV's SMR Rating (94) in the Biotechnology industry is in the same range as VTVT (100). This means that MNOV’s stock grew similarly to VTVT’s over the last 12 months.

VTVT's Price Growth Rating (35) in the Biotechnology industry is somewhat better than the same rating for MNOV (83). This means that VTVT’s stock grew somewhat faster than MNOV’s over the last 12 months.

VTVT's P/E Growth Rating (100) in the Biotechnology industry is in the same range as MNOV (100). This means that VTVT’s stock grew similarly to MNOV’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MNOVVTVT
RSI
ODDS (%)
N/A
Bearish Trend 3 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
84%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bearish Trend 3 days ago
85%
Bullish Trend 3 days ago
87%
MACD
ODDS (%)
Bearish Trend 3 days ago
81%
Bearish Trend 3 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
83%
Bullish Trend 3 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
82%
Bullish Trend 3 days ago
84%
Advances
ODDS (%)
Bullish Trend 17 days ago
69%
Bullish Trend 3 days ago
87%
Declines
ODDS (%)
Bearish Trend 3 days ago
86%
N/A
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
88%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 3 days ago
88%
View a ticker or compare two or three
Ad is loading...
MNOVDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VTVTDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BLZE9.310.35
+3.91%
Backblaze
TXN177.482.23
+1.27%
Texas Instruments
BBU19.150.15
+0.79%
Brookfield Business Partners LPLimited Partnership Units
IDN3.190.01
+0.31%
Intellicheck
SAIC129.470.35
+0.27%
Science Applications International Corp

MNOV and

Correlation & Price change

A.I.dvisor indicates that over the last year, MNOV has been loosely correlated with FATE. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if MNOV jumps, then FATE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MNOV
1D Price
Change %
MNOV100%
-0.76%
FATE - MNOV
36%
Loosely correlated
-1.81%
MNKD - MNOV
30%
Poorly correlated
+1.20%
VIR - MNOV
29%
Poorly correlated
+7.86%
QLGN - MNOV
28%
Poorly correlated
-2.19%
AXON - MNOV
28%
Poorly correlated
+0.65%
More

VTVT and

Correlation & Price change

A.I.dvisor indicates that over the last year, VTVT has been loosely correlated with VANI. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if VTVT jumps, then VANI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VTVT
1D Price
Change %
VTVT100%
+4.64%
VANI - VTVT
55%
Loosely correlated
-3.83%
TRAW - VTVT
25%
Poorly correlated
-1.87%
CYTO - VTVT
25%
Poorly correlated
+5.63%
MNOV - VTVT
25%
Poorly correlated
-0.76%
AUPH - VTVT
24%
Poorly correlated
+0.82%
More